Navigation Links
Aztreonam in Medical News

Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting

...d noncompetitive environment. Key topics will include: -- Advancements in drug discovery and development and the importance of clinical trials; -- aztreonam lysine for inhalation as a potential new CF therapy; -- Quality improvement and patient outcomes; -- The importance of newborn screening; and -- Se...
Aztreonam in Medical Technology

PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation

MONTEREY, Calif., Nov. 26 /PRNewswire/ -- PARI Pharma's eFlow electronic nebulizer was included in Gilead's (Nasdaq: GILD ) recent New Drug Application (NDA) submittal to the U.S. Food and Drug Administration (FDA) for marketing approval of aztreonam lysine for inhalation (75 mg three times d...

Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 29, 2007 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its Phase III AIR-CF1 (CP-AI-007) study of aztreonam lysine for inhalation for the treatment of people with cystic fibrosis (CF) who have pulmonary Pseudomonas aeruginosa (P. aeruginosa) me...

Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis

...c mean of the MIC in levofloxacin treated isolates increased less than two fold under anaerobic conditions, whereas tobramycin, amikacin and aztreonam treated isolates increased 4-7 fold under anaerobic conditions. This implies that MP-376 may retain its potency in anaerobic environments i...

Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections

...ed patients had a clinical cure rate of 91.6% compared to a vancomycin plus aztreonam clinical cure rate of 92.7% at test-of-cure (TOC) visit in the clinically e...d a microbiological eradication rate of 92.4% compared to a vancomycin plus aztreonam rate of 93.6% for all pathogens when used as treatment for cSSSI. The cefta...

Promising Cystic Fibrosis Compound on Track for Development

...e of Corus Pharmaceutical Company last year, acquired the rights to develop aztreonam lysine as an inhalation product to treat Pseudomonas aeruginosa infections. The company has said it will submit its new drug application (NDA) for aztreonam lysine to the FDA by the end of 2007. In the meantime, Gilead recently anno...

Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

... results of its Phase III AIR-CF2 study evaluating aztreonam lysine for inhalation, an antibiotic, in patients ...inosa). In the study, a 28-day treatment course of aztreonam lysine significantly improved the time to need for...ety and efficacy of a 28-day treatment course with aztreonam lysine for inhalation following a 28-day treatment...
Aztreonam in Medical Products

Antibiotic Level, Aztreonam

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories
Aztreonam in Biological Technology

Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush

...as a member of the scientific teams that developed a portfolio of leading hospital antibiotics including levofloxacin (Levaquin), doripenem (Doribax). aztreonam (Azactam) and piperacillin-tazobactam (Zozyn). Dr. Bush received her Ph.D. from the Indiana University Chemistry Department in 1970 and has s...

Horizon Therapeutics Announces Senior Management Appointments

...sed by Gilead Sciences, Inc. and was most recently vice president of operations at Corus where he was integral in the development and manufacturing of aztreonam lysinate for inhalation (AI). Additionally, he supervised the formulation and development of three additional drug candidates. Prior to Corus, ...

Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA

...feriority versus the combination of vancomycin and aztreonam in the treatment of complicated skin and skin stru...lar to those of the combination of vancomycin plus aztreonam (91.8% vs. 92.5%). MRSA eradication rates were als...cacy and Safety of Ceftaroline vs. Vancomycin plus aztreonam in Complicated Skin and Skin Structure Infections ...
Aztreonam in Biological Dictionary

Antibiotic

...icians. ... When is it okay for me to take antibiotics ? ... Information about antibiotic in the free online English dictionary and ... Azactam, aztreonam - an antibiotic (trade name Azactam) used against severe ... Antibiotic overuse is discussed. Dr. Greene explains when antibiotics should or ...
Other Tags
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
(Date:10/1/2014)... BOSTON (October 1, 2014) Despite a policy ... with developmental disabilities, this vulnerable population continues to ... of The Journal of the American Dental ... Medicine and Tufts University School of Dental Medicine ... factors influencing at-home oral care provided by caregivers ...
(Date:10/1/2014)... October 01, 2014 Insuranceragents.info has ... a good life insurance plan for vulnerable family members. ... vulnerable family members. Providers in the family should always ... cause financial hardships for the rest of the family. ... policies. Families can benefit more from temporary coverage or ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Phoseon Technology, ... , continues to expand the business worldwide. This rapid ... with additional capacity for manufacturing efforts. The company has ... last five years and expects this growth to continue ... curing technology gains worldwide adoption. , “We are ...
(Date:10/1/2014)... DURHAM, N.C. A new genetic finding from Duke ... hostility, anxiety and depression might also be hard-wired to ... diabetes and heart disease. , An estimated 13 percent ... the genetic susceptibility, and knowing this could help them ... healthy diet, exercise and stress management. , "Genetic susceptibility, ...
Breaking Medicine News(10 mins):Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Gene interacts with stress and leads to heart disease in some people 2
(Date:9/30/2014)... of Medicine reports positive results of a phase ... subset of lung cancer marked by rearrangement of the ... with advanced non-small cell lung cancer testing positive for ... with 3 complete responses and 33 partial responses. Median ... disease to resume its growth after being slowed by ...
(Date:9/30/2014)... (LMU) in Munich report that a new class ... to chemotherapeutic drugs. They have also pinpointed the ... for anti-tumor agents. , Researchers led by ... of the Technische Universitt Mnchen have identified a ... weapon in the fight against malignant tumors. The ...
(Date:9/30/2014)... of perilous threats in today,s ocean. From overfishing ... fragile coral ecosystems are disappearing at unprecedented rates ... of corals surrounding the island of Moorea in ... tropical environment: coral guard-crabs. New research from the ... scientist Seabird McKeon and the museum,s predoctoral fellow ...
Breaking Biology News(10 mins):NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2Cancer therapy: Driving cancer cells to suicide 2Smithsonian scientists discover coral's best defender against an army of sea stars 2
Other Contents